perioperative management of glp 1 agonists Considerations for Patients on GLP1 GLP-1 receptor agonists like semaglutide

Pemvidutide is a balanced dual agonist, meaning that it does not preferentially activate GLP1R or GR over the other [39]

A careful medical history is essential

In this article, we will conclude with the potential pharmacological mechanisms of GLP-1 treatment for MASLD, including clinical insights into GLP-1RAs and co-agonist drugs

2022Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

Through these mechanisms, GLP-1RAs activate multiple pathways, reduce inflammation, improve mitochondrial function, modulate proteostasis, and promote synaptic plasticity (4852), a profile well suited to the multifactorial nature of NDDs

Overall the trials established that liraglutide together with diet and exercise maintained weight loss and induced further weight loss over 56 weeks